Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",42019,231,1.04 [0.90-1.21],0.5784675945754536
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43472,329,1.04 [0.93-1.16],0.4986496118853268
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",43038,2279,1.09 [1.04-1.13],4.254451991693673e-05
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Candidiasis,43511,696,0.98 [0.90-1.07],0.7112008824180709
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,42181,5810,1.05 [1.02-1.08],0.0002137845224075
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42387,5291,1.08 [1.05-1.11],2.1181855672528e-07
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,43093,2016,1.03 [0.98-1.07],0.214857377415901
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,43357,144,1.07 [0.88-1.29],0.5114541875027211
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,40105,1578,1.10 [1.05-1.16],0.0002238112868159
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38702,1760,1.15 [1.10-1.21],1.8300274052411543e-08
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38581,413,1.06 [0.95-1.18],0.2746001127581612
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30524,3254,1.09 [1.05-1.13],1.3796735115997254e-05
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38331,641,1.16 [1.08-1.24],3.877403255997543e-05
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43446,2369,1.03 [0.99-1.07],0.1667224107955819
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Mycoses,43638,823,1.01 [0.94-1.09],0.8362764709562223
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,42281,1522,1.12 [1.07-1.17],3.698026960129101e-06
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43528,1740,1.09 [1.03-1.14],0.0009335952369556
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41408,331,1.04 [0.93-1.16],0.4613004799368625
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43731,77,1.04 [0.80-1.36],0.765502339626049
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,43311,1523,1.09 [1.03-1.15],0.002153354487095
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,43341,128,0.97 [0.81-1.15],0.7044237545833476
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43588,263,1.02 [0.93-1.12],0.6942762213369327
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43558,233,1.01 [0.92-1.12],0.8176479736354756
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41444,685,1.03 [0.95-1.11],0.5212894857704112
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,41215,456,1.06 [0.98-1.16],0.150089098875263
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,41243,166,1.07 [0.92-1.25],0.3632154532329028
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43691,93,0.97 [0.77-1.22],0.7902767954475561
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43615,261,1.05 [0.94-1.18],0.3633597867995695
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral warts,43441,87,1.09 [0.91-1.31],0.3294042484506927
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43470,116,1.03 [0.87-1.23],0.715702575256864
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm,43234,495,1.03 [0.95-1.11],0.4783331286771023
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43583,101,1.07 [0.93-1.22],0.3344646604923884
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43542,106,1.03 [0.89-1.19],0.7027108739671989
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20024,102,1.09 [0.77-1.57],0.6203155400060564
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",43162,2421,1.02 [0.98-1.07],0.248777027392565
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of meninges,43706,98,0.95 [0.77-1.17],0.6353035193164429
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43622,114,1.17 [1.01-1.34],0.0356351685653846
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43687,180,1.07 [0.95-1.21],0.247444867727812
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of ovary,23600,148,0.97 [0.86-1.09],0.6007475415144095
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,43688,615,1.06 [0.97-1.16],0.1690714586251489
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Caecum,43697,503,0.99 [0.89-1.10],0.8100308348221565
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43538,123,0.95 [0.76-1.18],0.6225518601327316
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Descending colon,43690,371,1.15 [1.05-1.26],0.0028558435111224
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Rectum,43613,589,1.06 [0.98-1.15],0.1667401118621689
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43531,1070,1.02 [0.95-1.08],0.5914866336381672
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,43679,715,1.07 [0.98-1.16],0.1180280072113786
RLN2,Prorelaxin H2,Chapter II Neoplasms,Carcinoma in situ of breast,19155,120,0.97 [0.86-1.10],0.668554455798654
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19225,138,0.97 [0.87-1.10],0.670173990644821
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",34853,92,1.00 [0.77-1.30],0.997593668897826
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",34879,118,0.86 [0.64-1.16],0.3181670390568169
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43643,203,0.99 [0.87-1.14],0.936447620029787
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma, any site",43644,198,0.99 [0.87-1.14],0.923154983439404
RLN2,Prorelaxin H2,Chapter II Neoplasms,Leiomyoma of uterus,22803,498,1.09 [1.05-1.13],3.887055279686927e-05
RLN2,Prorelaxin H2,Chapter II Neoplasms,Lung cancer and mesothelioma,30347,579,1.05 [0.95-1.16],0.3366674846652994
RLN2,Prorelaxin H2,Chapter II Neoplasms,Lymphoid leukaemia,34850,89,1.00 [0.77-1.31],0.9877968249136544
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",35071,310,1.08 [0.98-1.19],0.1317342473537406
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",35091,330,1.08 [0.93-1.26],0.2870003997975667
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19354,164,1.11 [1.00-1.25],0.059847783370019
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",34898,137,1.05 [0.86-1.29],0.6160221842428582
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",34939,178,1.28 [1.13-1.45],0.0001026936336811
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",34936,175,0.91 [0.71-1.15],0.4281321037689793
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19316,126,0.89 [0.73-1.09],0.2553553880047954
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",34920,159,0.92 [0.74-1.14],0.4339891485642894
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16714,1143,1.17 [1.06-1.29],0.0026765861466351
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",34953,192,0.92 [0.76-1.13],0.4290763709120735
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",34888,127,0.88 [0.66-1.17],0.3751206376265745
RLN2,Prorelaxin H2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,34934,173,1.18 [1.02-1.36],0.021375435003676
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi,43400,347,1.05 [0.97-1.13],0.2277787744787888
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi of trunk,43666,152,1.13 [1.01-1.26],0.0364157105376975
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanoma in situ,34818,138,1.09 [0.91-1.30],0.3634008052870631
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",34921,160,0.95 [0.76-1.17],0.6130967289228356
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",35033,272,1.02 [0.89-1.16],0.8040678341543944
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",35160,399,0.98 [0.85-1.14],0.8325452404160936
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",34929,168,1.09 [0.93-1.27],0.288913962721596
RLN2,Prorelaxin H2,Chapter II Neoplasms,Other benign neoplasms of skin,43429,272,1.09 [0.99-1.19],0.074907487282781
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36562,1801,1.02 [0.96-1.08],0.5721522848799396
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36657,1896,1.03 [0.98-1.09],0.2595050841692192
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,43231,575,1.03 [0.95-1.11],0.4788980891580058
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40603,146,1.22 [1.05-1.43],0.0115141830139988
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42780,124,1.10 [0.97-1.26],0.1388716818496154
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42419,4808,1.08 [1.05-1.11],3.374831339397219e-08
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,41305,78,1.16 [0.87-1.54],0.3102870312779077
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,43034,89,1.26 [1.09-1.46],0.0017580158754144
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,42940,2483,1.09 [1.05-1.13],1.091834324899631e-05
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,42938,2481,1.09 [1.05-1.13],1.239012929907734e-05
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40599,142,1.13 [0.97-1.33],0.1183256787002004
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,43186,1959,1.08 [1.04-1.13],0.0001336672765264
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,43136,191,1.09 [0.97-1.22],0.1504619902743144
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42760,104,0.96 [0.76-1.20],0.7190487463083048
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42761,105,1.14 [0.97-1.34],0.1210235897153545
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,43412,467,1.13 [1.04-1.23],0.004179682875899
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43555,92,1.02 [0.88-1.18],0.7874832024716266
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",43332,387,1.10 [1.00-1.21],0.0537182062299029
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41401,174,1.10 [0.96-1.25],0.1557841809488825
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,34001,506,1.09 [0.99-1.20],0.096126303966593
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40780,191,0.95 [0.80-1.12],0.5414935322893827
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,40806,217,0.97 [0.82-1.14],0.6918448309353493
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33590,95,1.12 [0.91-1.37],0.2770949456229044
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40653,106,0.91 [0.74-1.11],0.3427499053676668
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39709,387,1.07 [0.96-1.19],0.2087655178266275
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",42963,889,1.03 [0.92-1.14],0.6508853249057898
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42527,453,1.10 [0.94-1.29],0.2359464766959071
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,42251,177,0.81 [0.61-1.07],0.1362305254844521
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,43153,2606,0.99 [0.96-1.03],0.713765096896509
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,38187,2535,0.99 [0.96-1.03],0.7453137566943625
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33596,101,1.14 [0.96-1.36],0.1328119660805821
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40394,136,0.81 [0.64-1.03],0.0913597355891167
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,33953,458,1.09 [0.99-1.20],0.0698429579654368
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33596,101,1.04 [0.86-1.26],0.6642383256192965
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,39382,5887,0.99 [0.96-1.02],0.6389844819738
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33824,329,0.94 [0.81-1.09],0.428735518035314
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34415,920,1.03 [0.96-1.11],0.4392696519060116
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43599,528,1.07 [0.99-1.15],0.0720006984141036
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,43283,212,1.13 [1.02-1.26],0.021967168466245
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33705,210,0.96 [0.81-1.15],0.685683372942191
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33598,103,1.14 [0.94-1.39],0.1852588244628327
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,42821,2563,1.01 [0.98-1.05],0.4951039326594397
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,33920,425,1.25 [1.14-1.37],2.462344690139653e-06
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,33950,455,1.25 [1.15-1.37],6.49370482459796e-07
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34541,1046,1.04 [0.97-1.12],0.2417919131410775
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33677,182,1.09 [0.91-1.31],0.3598008206581986
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,43273,202,1.14 [1.03-1.27],0.0132135116348956
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34505,1010,0.95 [0.87-1.04],0.2708118072713932
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,34296,801,1.07 [1.00-1.15],0.0521913758341822
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39432,110,0.99 [0.83-1.18],0.8980109910961758
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41816,8321,1.01 [0.99-1.04],0.4093449693676454
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,40332,74,0.93 [0.74-1.16],0.5162605459895365
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,40356,98,0.96 [0.81-1.14],0.6188157003340868
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43426,3251,1.00 [0.97-1.04],0.8575363269391065
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43426,3245,1.00 [0.97-1.04],0.8301600095269454
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,40345,87,1.03 [0.86-1.24],0.7191242757212519
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,43152,2038,1.00 [0.96-1.03],0.8549393307031775
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",36106,2611,1.07 [1.03-1.12],0.0018461411122765
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43711,351,1.06 [0.94-1.20],0.333909894992171
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,42195,121,1.01 [0.77-1.32],0.9312102455764506
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,41289,175,1.04 [0.91-1.18],0.5722964163890008
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,41355,241,1.04 [0.92-1.16],0.5493197108875625
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33769,274,1.05 [0.94-1.16],0.4102356617914641
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39816,263,1.04 [0.91-1.18],0.5932910028818442
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3601,140,1.04 [0.83-1.29],0.7536745870328252
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3828,411,0.98 [0.86-1.11],0.7108358518517152
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39658,105,1.16 [0.92-1.45],0.2136480005367677
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3539,79,1.22 [1.00-1.48],0.0471724505833357
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42682,3129,1.02 [0.98-1.06],0.4382874947576434
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42636,562,1.17 [1.03-1.34],0.0151743247163122
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,39930,608,1.05 [0.98-1.13],0.1593546224431948
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34735,1240,1.07 [1.00-1.14],0.0519810470864969
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43536,411,0.99 [0.88-1.10],0.8112781366626056
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),41837,276,1.15 [0.96-1.38],0.1307018116724677
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Angina pectoris,40013,1974,1.02 [0.97-1.08],0.4695731181630999
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,41968,407,1.05 [0.90-1.22],0.5717416156625893
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41656,95,0.84 [0.58-1.21],0.3566583549790348
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",41886,325,0.96 [0.82-1.13],0.6361679982077219
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,27157,3175,1.00 [0.95-1.06],0.8804111139553433
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,AV-block,36932,711,1.07 [0.96-1.19],0.2524038740145376
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43632,693,1.03 [0.94-1.13],0.5239109373116697
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cardiac arrest,24297,315,1.14 [1.00-1.29],0.0442663090235612
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36507,286,0.99 [0.86-1.15],0.9431074405123744
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36381,160,1.00 [0.84-1.20],0.9891429880000594
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43727,76,1.15 [0.87-1.52],0.328810179968549
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Conduction disorders,37974,1753,1.03 [0.96-1.10],0.4267166985236098
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41477,3469,1.01 [0.97-1.06],0.6058123641849975
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,38297,12858,1.00 [0.99-1.02],0.6409344365277606
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,41408,446,1.00 [0.90-1.11],0.996260262377612
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Endocarditis,36338,117,1.16 [0.96-1.38],0.1166369295295493
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",43384,1825,1.06 [0.99-1.13],0.0751109004765959
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertension,39827,10985,1.01 [0.99-1.03],0.2476649634530663
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",39840,10998,1.01 [0.99-1.04],0.2133937314366006
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",43433,135,0.94 [0.72-1.22],0.6373065462022024
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29162,320,1.22 [1.10-1.36],0.0002359075085857
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,29010,168,1.45 [1.30-1.63],1.4040165152499047e-10
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypotension,43492,1912,1.06 [1.01-1.12],0.0223965326053204
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,42204,181,0.78 [0.60-1.00],0.0521353562165199
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41769,3730,1.01 [0.97-1.05],0.7234900488948628
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",43116,935,1.02 [0.93-1.11],0.7092737573166779
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,36828,607,0.96 [0.85-1.08],0.4890257553735518
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,42956,1417,0.98 [0.92-1.05],0.6354610808101641
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",39233,1194,1.02 [0.95-1.09],0.6140535817281443
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43569,270,1.01 [0.87-1.17],0.9242407122115652
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43680,520,0.94 [0.83-1.06],0.3051833449068415
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Oesophageal varices,41051,89,1.19 [0.98-1.45],0.0811711891210049
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other aneurysm,41690,129,1.08 [0.90-1.31],0.3973859023585679
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other arrhythmias,36936,715,1.10 [1.02-1.19],0.0201340089523898
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41729,168,0.93 [0.74-1.17],0.5524525273380302
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41955,394,1.16 [1.05-1.27],0.002441108777789
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36525,304,0.98 [0.85-1.12],0.7393435043976874
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other disorders of veins,41114,152,0.96 [0.79-1.16],0.6632889739383927
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,41046,84,1.04 [0.86-1.26],0.6932209289880208
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,41374,104,0.98 [0.74-1.30],0.8742495290634916
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,41184,222,1.04 [0.91-1.19],0.5892056464245818
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37919,1698,1.08 [1.02-1.14],0.0139166572417418
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41672,92,1.04 [0.83-1.30],0.7553917562285115
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42475,914,1.08 [1.01-1.15],0.0310184659282616
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42692,600,1.16 [1.06-1.27],0.0008549730549758
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",42272,1002,1.02 [0.92-1.12],0.7479714425751187
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24539,557,1.07 [0.98-1.17],0.1190435063399088
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,42180,674,1.11 [1.01-1.22],0.0295996973215325
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41537,575,0.99 [0.91-1.09],0.9139353218281424
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,42878,786,1.05 [0.98-1.13],0.1879353479296048
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43611,1079,1.07 [0.99-1.15],0.0973261886526964
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,36802,581,1.10 [0.98-1.22],0.1001883690460601
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,42684,592,1.17 [1.07-1.28],0.0007535616873706
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41583,313,1.07 [0.94-1.22],0.3028603781360836
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",43095,1072,0.97 [0.90-1.06],0.5519319972789585
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",43061,1136,0.99 [0.91-1.07],0.7193546945965263
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,42156,98,0.99 [0.81-1.21],0.9028848012340904
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41690,130,0.80 [0.59-1.08],0.1448998812039402
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,42560,379,1.08 [0.97-1.21],0.1602761760878019
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41970,431,0.92 [0.81-1.06],0.2419173140392697
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Varicose veins,41659,697,1.04 [0.97-1.12],0.2888351294209723
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41586,141,1.02 [0.84-1.24],0.8371287385168901
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,43339,1237,1.00 [0.94-1.07],0.8839917498854866
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43527,608,0.94 [0.85-1.03],0.1756932746316684
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",38337,2406,1.00 [0.97-1.04],0.8198370479693637
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Any mental disorder,42639,6708,1.01 [0.98-1.03],0.6005487832595868
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43450,712,0.94 [0.86-1.02],0.1469789410807296
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38584,2653,0.99 [0.96-1.02],0.6326845041902244
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",36068,137,1.11 [0.98-1.26],0.0992408549152995
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Smoking dependency,42821,2318,1.01 [0.97-1.06],0.5734196591582774
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38685,2754,1.00 [0.96-1.04],0.9564113882676084
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Vascular dementia,42928,209,0.83 [0.63-1.09],0.185283749591238
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Alzheimer disease,43729,564,1.08 [0.95-1.24],0.2501446710869989
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",29650,100,0.62 [0.41-0.94],0.0226126568414027
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Bell's palsy,40732,137,1.01 [0.86-1.17],0.9354316298974475
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41439,844,0.94 [0.88-1.01],0.1004581168866908
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Cerebral cysts,43047,372,1.07 [0.98-1.17],0.1295810368864114
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43594,525,0.97 [0.87-1.08],0.6225473205769536
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,42906,93,0.82 [0.56-1.18],0.2789818937731018
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43703,109,1.09 [0.92-1.30],0.3193051687336399
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",42793,118,0.98 [0.80-1.22],0.8853745232046139
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Epilepsy,41133,471,0.93 [0.85-1.03],0.1845807481955538
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,42923,2261,1.03 [0.99-1.07],0.1346501810790907
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43652,693,0.96 [0.86-1.07],0.4841620834433808
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,42740,4254,1.02 [0.99-1.06],0.2149057341922211
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Generalized epilepsy,43100,88,0.92 [0.74-1.15],0.4648216285200657
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Hemiplegia,43480,411,1.00 [0.89-1.13],0.9882411525452476
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Hydrocephalus,42778,103,1.04 [0.87-1.26],0.6433201689835637
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43698,116,1.07 [0.92-1.23],0.3836187397503089
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40722,127,0.96 [0.83-1.10],0.5223891623919905
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40725,130,1.15 [1.00-1.31],0.0426416832366078
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Memory loss,42686,200,1.04 [0.89-1.22],0.6197771166084981
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Migraine,41261,599,1.05 [1.00-1.10],0.06936324654038
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43612,543,1.05 [1.00-1.11],0.0609313269798057
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Motor neuron disease,29842,255,0.98 [0.84-1.14],0.7778904582507243
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43439,186,1.01 [0.92-1.11],0.8773495287534303
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42611,2016,1.00 [0.96-1.04],0.8218956773249144
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Neurological diseases,41230,6154,1.02 [0.99-1.04],0.1396248888607238
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,43122,309,0.94 [0.78-1.13],0.4891408497940875
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",41274,679,1.03 [0.96-1.10],0.4163333872588336
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43604,493,1.06 [0.97-1.17],0.1874406611004008
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,35003,1086,1.08 [1.01-1.16],0.032843986820126
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,42794,119,1.00 [0.82-1.21],0.9769840598057712
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,42911,236,1.08 [0.96-1.21],0.2251734234107315
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,43205,246,1.09 [0.96-1.25],0.1780883031332987
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,40757,162,1.02 [0.89-1.17],0.7724514897663599
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other headache syndromes,40764,102,1.05 [0.91-1.22],0.4895172519913719
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other neurological diseases,43533,858,1.05 [0.99-1.12],0.1271628534378497
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other sleep disorders,41584,922,1.02 [0.96-1.09],0.4705164521168014
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Parkinson's disease,43685,407,0.90 [0.76-1.07],0.2443542166403018
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,42769,94,1.01 [0.88-1.16],0.8768442659549264
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Restless leg syndrome,43727,108,1.09 [0.91-1.31],0.3657151096608608
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Sleep apnoea,43331,801,1.04 [0.97-1.11],0.2621769032601105
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,43194,83,1.11 [0.90-1.36],0.3175717625425978
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43703,299,0.97 [0.84-1.10],0.6090649637879008
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40680,85,1.07 [0.88-1.30],0.498057341710292
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43729,570,1.08 [0.94-1.24],0.2607087960480762
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),42861,202,0.83 [0.63-1.10],0.193742058710096
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,42783,160,1.12 [0.94-1.33],0.2212944018579596
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,43039,659,0.90 [0.81-1.01],0.0771716626998799
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43459,387,0.97 [0.85-1.10],0.6159936805908144
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,42024,93,0.77 [0.54-1.08],0.129256916571361
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,42029,98,1.12 [0.99-1.28],0.0759370382265814
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43543,92,1.03 [0.83-1.29],0.77023250236309
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,43290,245,0.99 [0.83-1.18],0.8974021016574428
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3546,85,1.23 [1.04-1.46],0.0181372847090258
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4282,164,1.11 [0.95-1.31],0.1912176311481873
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,42787,164,0.87 [0.71-1.06],0.1730510056888337
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,43390,1746,0.96 [0.90-1.02],0.1677138454990787
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",43102,1171,1.02 [0.96-1.09],0.5506670594556935
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,42305,374,0.98 [0.87-1.10],0.7153075888033931
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43592,1212,0.91 [0.85-0.98],0.0185100093706273
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43717,117,1.03 [0.85-1.23],0.7878461822313252
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43471,1091,0.91 [0.84-0.99],0.0246962676524493
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43659,614,0.89 [0.79-1.00],0.0502779873993178
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43569,315,0.96 [0.84-1.09],0.5078469199425752
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,42035,104,1.07 [0.80-1.43],0.6388000487037967
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,42047,116,0.80 [0.57-1.13],0.2131405879201972
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,42026,95,0.94 [0.72-1.23],0.6415316909473416
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43571,1190,0.95 [0.88-1.03],0.2364474517363278
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42695,314,0.82 [0.67-0.99],0.0399748874328198
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42459,79,1.10 [0.86-1.40],0.4587976624639682
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,43217,172,0.72 [0.55-0.95],0.0180679699176791
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43501,456,0.95 [0.84-1.08],0.454932542861902
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42711,331,0.92 [0.81-1.05],0.2035234992004694
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43444,190,0.94 [0.79-1.12],0.491238585459878
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,43157,776,0.97 [0.88-1.07],0.5552838080189368
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,42855,232,1.02 [0.90-1.15],0.7821635605723954
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,41052,3696,0.94 [0.90-0.99],0.0119986241347045
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43442,397,0.91 [0.79-1.06],0.2334597737415629
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43694,258,1.02 [0.90-1.16],0.7832823804266075
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42634,703,0.99 [0.90-1.09],0.8010314323154593
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,43162,117,0.72 [0.51-1.02],0.0635126585460331
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43693,93,0.98 [0.77-1.25],0.8700662298361489
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,42074,143,1.14 [0.97-1.35],0.1155088339791753
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,42188,257,0.97 [0.84-1.13],0.7065550131239186
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,41843,199,0.88 [0.70-1.10],0.247210868489095
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42476,96,1.03 [0.87-1.22],0.767770849292574
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41756,112,0.86 [0.67-1.10],0.2235373798079697
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42525,144,0.82 [0.64-1.06],0.1294469576915149
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42706,325,0.97 [0.83-1.13],0.685869576715658
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,42140,209,1.02 [0.87-1.19],0.8104972008285963
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,41833,189,0.87 [0.74-1.03],0.1186165802262522
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,41778,134,1.03 [0.81-1.31],0.8014271907157575
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40357,3001,0.92 [0.87-0.97],0.0031280483848118
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,42055,124,1.05 [0.88-1.25],0.5921753566705068
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,43312,689,1.00 [0.92-1.08],0.9126355563604766
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42723,100,1.06 [0.84-1.34],0.6229016124847045
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),42887,264,1.06 [0.94-1.19],0.3628932500824187
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,43353,151,1.00 [0.86-1.18],0.9546050973993228
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43652,200,1.15 [1.04-1.28],0.0083349730261507
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43506,218,0.99 [0.88-1.11],0.8961406007527808
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,43311,109,1.00 [0.83-1.20],0.9991553128939168
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,43308,106,1.10 [0.95-1.28],0.1973849292738719
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43553,1484,0.98 [0.92-1.05],0.6226687478836075
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,43129,1060,0.96 [0.88-1.05],0.3976199687479873
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,42279,210,1.04 [0.90-1.21],0.5719956782483332
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,42215,146,0.86 [0.69-1.07],0.1878898543617678
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute pharyngitis,43303,118,1.11 [0.99-1.25],0.0859448370201814
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43545,360,1.10 [1.03-1.18],0.0068144711627424
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,43290,105,1.12 [0.98-1.28],0.1029742671334847
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,All influenza,40363,199,1.16 [1.03-1.30],0.0180354977019955
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40359,195,1.16 [1.03-1.31],0.0143970804378568
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),29968,200,1.08 [0.98-1.20],0.1116881545076818
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Allergic rhinitis,43523,474,0.97 [0.89-1.05],0.4297508074781976
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32346,3027,1.03 [1.00-1.06],0.0921437938779995
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32747,2979,1.02 [0.99-1.05],0.1628196677442588
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),43040,239,1.21 [1.09-1.34],0.0003078097007507
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",40302,138,1.22 [1.06-1.40],0.0046349848893702
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Bronchiectasis,37844,588,1.07 [0.98-1.18],0.1293764476864967
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37353,97,1.19 [1.02-1.39],0.0265878963059418
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,42002,4746,1.04 [1.01-1.07],0.0078793695698717
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41393,123,1.03 [0.87-1.21],0.7311786390460553
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic sinusitis,41525,255,0.95 [0.84-1.07],0.4146656487273649
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",43389,1997,1.02 [0.96-1.08],0.5423817032666811
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Deviated nasal septum,41457,187,0.98 [0.86-1.13],0.8126661574160112
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40205,8851,1.06 [1.04-1.08],6.189808847012272e-08
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41898,628,1.03 [0.97-1.10],0.3433578246347759
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Early onset COPD,41944,552,0.96 [0.90-1.04],0.3113192811149977
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Emphysema,37793,537,1.04 [0.94-1.16],0.4276627140288357
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41480,505,1.20 [1.09-1.32],0.000231264135081
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,43343,3179,1.09 [1.05-1.13],4.783767306528409e-06
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Interstitial lung disease,41537,562,1.20 [1.10-1.31],5.232981411269497e-05
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Later onset COPD,41984,1445,0.97 [0.88-1.06],0.4902458864161305
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43708,515,0.98 [0.86-1.11],0.7272514148456648
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Nasal polyp,41462,192,0.98 [0.84-1.14],0.7897416060305409
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,43294,1626,1.09 [1.04-1.14],0.0006226445104721
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of pleura,43331,3349,1.09 [1.05-1.13],2.489916811530485e-06
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42691,1421,1.01 [0.96-1.06],0.7145065137017453
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other pleural conditions,40067,85,1.00 [0.76-1.30],0.975863783008444
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43557,693,1.21 [1.13-1.30],1.725301708349014e-07
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43550,2199,1.09 [1.04-1.14],0.0001152949241275
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pleural effusion,41627,1645,1.11 [1.06-1.17],4.239336235395762e-05
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pleural plaque,40246,264,1.05 [0.86-1.29],0.6440686973965417
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",42917,2753,1.09 [1.05-1.14],2.9717994035698867e-05
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43594,401,0.97 [0.84-1.11],0.6313504711079774
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pneumothorax,40190,208,1.11 [0.95-1.30],0.1806442784568942
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pollen allergy,43694,405,0.97 [0.89-1.06],0.5303128905911089
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pulmonary oedema,42972,108,1.26 [1.08-1.47],0.0027788957820783
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,29860,92,1.13 [0.91-1.41],0.2626894045550645
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,43259,1591,1.09 [1.04-1.15],0.0004529740572679
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41745,475,0.97 [0.89-1.05],0.4300234971115799
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Viral pneumonia,40572,408,1.08 [0.98-1.19],0.1418636763904372
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",43068,335,1.06 [0.95-1.18],0.3152600290368198
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20179,187,1.12 [0.99-1.26],0.0686797225442871
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30979,106,1.11 [0.94-1.30],0.2310303903565956
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute appendicitis,43452,240,0.99 [0.89-1.10],0.8274115609455223
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute gastritis,32973,141,1.11 [0.97-1.28],0.1393251101425154
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute pancreatitis,40611,314,1.00 [0.89-1.12],0.9891167317547525
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute peritonitis,42924,150,1.10 [0.96-1.27],0.1686966207301227
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,42228,127,0.92 [0.73-1.16],0.4806625982367315
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Barrett oesophagus,33575,743,0.96 [0.88-1.05],0.3851928348315678
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40469,172,1.00 [0.81-1.22],0.968379893168572
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",43022,172,0.99 [0.80-1.22],0.9010719836034572
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholecystitis,40637,340,1.11 [1.02-1.22],0.022553836826784
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholelithiasis,42005,1708,1.06 [1.01-1.10],0.0072467252637654
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Chronic gastritis,33342,510,0.98 [0.89-1.07],0.6245238200894014
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,40381,84,0.96 [0.76-1.22],0.768016212121496
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43484,186,1.18 [1.03-1.35],0.01681516494975
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Coeliac disease,41039,201,1.02 [0.90-1.14],0.7936296255435822
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Collagenous colitis,40868,135,1.05 [0.91-1.22],0.4690676354912984
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43464,320,1.00 [0.90-1.10],0.961212033179504
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Constipation,43301,2753,1.02 [0.98-1.06],0.3660221167099291
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn disease,40884,151,1.07 [0.94-1.21],0.3107334950004046
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",43124,107,1.00 [0.83-1.21],0.999119424172387
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40873,140,1.04 [0.91-1.19],0.5758861258020154
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Dental caries,42471,380,1.04 [0.96-1.13],0.2972415681474096
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,39245,3728,1.03 [0.99-1.06],0.1046902725058618
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of appendix,43513,301,1.00 [0.91-1.09],0.9732251823520466
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of liver,43523,1422,1.02 [0.97-1.07],0.4809777088141757
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",40052,7220,0.99 [0.97-1.01],0.4504195993056468
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",43019,928,1.02 [0.97-1.08],0.3916372889517439
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43589,815,1.09 [1.03-1.15],0.0021541491145143
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,42283,192,0.97 [0.85-1.10],0.6121641869699723
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,42042,108,0.99 [0.84-1.17],0.894657984178908
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,43212,2374,1.03 [0.99-1.07],0.1003136432626198
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of tongue,42052,182,0.93 [0.80-1.08],0.3331514949278215
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42692,2395,1.04 [1.00-1.08],0.0377308412518937
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36193,5320,1.00 [0.98-1.03],0.8129842574771141
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Duodenal ulcer,33163,331,1.11 [0.99-1.23],0.0734393448535775
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43579,263,1.04 [0.91-1.19],0.5770462401003351
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43589,90,1.10 [0.99-1.23],0.0662654114601268
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,42323,222,1.14 [1.00-1.29],0.0463834150259766
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31121,248,0.98 [0.87-1.10],0.7010366705693476
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Functional dyspepsia,33768,936,1.01 [0.96-1.07],0.602439415058961
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastric ulcer,33433,601,1.01 [0.93-1.10],0.7812916522017602
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,37028,4196,0.99 [0.96-1.02],0.6586156590981833
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33731,899,1.05 [0.98-1.12],0.1629246284268162
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,33845,13909,1.00 [0.99-1.02],0.7296599446592666
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,GI-bleeding,42766,1928,1.01 [0.97-1.06],0.5286685605860308
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,42194,103,0.81 [0.63-1.04],0.100898556619364
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32500,2105,1.00 [0.96-1.04],0.9005428452306388
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",42205,104,0.80 [0.58-1.11],0.1825728316795049
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Hernia,40955,5438,1.03 [1.00-1.06],0.0405434152465712
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Impacted teeth,43600,84,1.08 [0.96-1.21],0.2112964798456052
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Impaction of intestines,30968,95,1.09 [0.90-1.32],0.3707597251960437
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Inguinal hernia,37039,1522,1.00 [0.93-1.09],0.944942946354562
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35686,169,0.93 [0.70-1.23],0.6005946756921765
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,31032,159,0.98 [0.83-1.16],0.8410796106462853
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,41079,241,1.08 [0.98-1.18],0.1134395370522265
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31807,934,0.98 [0.93-1.03],0.3651688997062167
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43680,617,1.00 [0.93-1.08],0.9612701472714482
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,42007,1274,1.02 [0.97-1.07],0.461163514271855
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42428,1695,1.01 [0.97-1.06],0.6626762719613204
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,33138,306,1.06 [0.94-1.19],0.3610073776407408
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophagitis,33853,1021,1.02 [0.95-1.08],0.6429109044184812
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43640,228,0.97 [0.86-1.10],0.6551721551436951
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35628,111,1.16 [0.99-1.36],0.0745369198564911
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33160,2287,0.99 [0.95-1.03],0.5388882710170841
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40765,468,0.98 [0.88-1.09],0.6851793086293723
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40563,266,1.03 [0.93-1.14],0.6115305804068614
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestine,33830,2957,0.99 [0.95-1.03],0.500375322224635
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestines,40310,9437,0.99 [0.97-1.01],0.4355044440449115
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,42023,350,0.94 [0.84-1.05],0.2438974432829015
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of liver,43260,1159,1.01 [0.95-1.07],0.6897357758902416
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,33970,1138,0.99 [0.93-1.06],0.8568248881213651
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,40543,246,1.00 [0.85-1.17],0.9579852360606024
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43477,703,1.08 [1.02-1.15],0.0074948341392724
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34425,1593,0.99 [0.94-1.05],0.7979028051732264
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,42792,1954,1.02 [0.97-1.06],0.451498888774306
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,42389,298,0.91 [0.80-1.04],0.1518449400097934
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33707,2834,1.02 [0.98-1.06],0.3052076301063537
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),36198,3366,1.00 [0.96-1.03],0.8714492528110117
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,42272,171,1.08 [0.95-1.23],0.2344798565986379
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,42220,1487,1.02 [0.97-1.07],0.3887387388562309
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31449,576,1.06 [0.97-1.15],0.1972651271180417
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43571,107,1.09 [0.99-1.21],0.0795169259150723
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31693,820,1.02 [0.95-1.10],0.5752770545908026
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",41099,261,1.10 [0.99-1.22],0.0777027391582714
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,43707,95,0.90 [0.74-1.11],0.3396319926912731
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,42096,189,0.93 [0.82-1.07],0.3204944648902431
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Toxic colitis,40826,93,1.11 [0.89-1.38],0.3715661495739548
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33299,467,0.97 [0.87-1.09],0.6464776760355049
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcerative colitis,41008,275,0.99 [0.89-1.11],0.8972245933559237
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40963,230,1.01 [0.91-1.13],0.7891407100787047
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Umbilical hernia,35971,454,1.06 [0.96-1.15],0.2418149277408188
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,31168,295,1.03 [0.91-1.18],0.6232871456868919
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ventral hernia,35951,434,1.08 [0.99-1.17],0.0729398428874399
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Volvulus,31006,133,0.95 [0.80-1.14],0.6185888935607136
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43602,487,1.06 [0.96-1.18],0.2479556496347266
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,43191,133,1.03 [0.90-1.18],0.6731670955729245
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,40314,268,1.01 [0.91-1.11],0.8971713057836279
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42635,1185,1.03 [0.97-1.10],0.3096113757807864
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41748,298,0.97 [0.86-1.08],0.5539792636144414
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40686,640,1.14 [1.04-1.25],0.0073263623499069
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,43208,464,1.08 [1.00-1.17],0.0591318929962844
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43545,801,1.03 [0.97-1.11],0.3192538008951713
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,42827,83,1.13 [0.97-1.32],0.1288113207355736
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,41087,5360,1.03 [1.00-1.06],0.0285592676498203
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42958,735,1.02 [0.95-1.08],0.6077611847763291
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42734,511,1.00 [0.92-1.08],0.9100796305285704
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,43050,1600,1.01 [0.96-1.06],0.7175165537617327
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43701,90,0.83 [0.64-1.07],0.150311441245907
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,40153,107,1.04 [0.90-1.21],0.5912817004811796
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,42313,90,1.13 [0.94-1.36],0.2058498650631823
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,43190,446,1.08 [1.00-1.17],0.0603173740060761
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40810,764,1.06 [0.99-1.14],0.1080911479159383
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,40160,114,1.00 [0.79-1.27],0.9907023166275872
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43581,138,1.08 [0.93-1.26],0.3031475714140759
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41752,302,0.94 [0.82-1.09],0.4155054802637027
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,43387,329,1.01 [0.89-1.13],0.9041542904452772
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,42843,99,1.15 [0.90-1.46],0.273694393214927
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,40155,109,1.11 [0.95-1.29],0.1980116829375883
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,42757,2711,1.06 [1.02-1.11],0.0015191076930435
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40875,829,1.08 [1.01-1.15],0.0310503183844912
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,40167,121,1.04 [0.84-1.28],0.7433490827744312
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43582,524,1.01 [0.93-1.09],0.8744516346315004
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,42862,118,0.85 [0.68-1.08],0.1851489153545415
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43489,431,1.04 [0.95-1.14],0.3862302683164709
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43645,530,1.08 [0.98-1.19],0.1391996953688776
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,40257,211,0.98 [0.87-1.10],0.6919195465781999
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40495,449,0.99 [0.89-1.10],0.8507638269623559
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43628,513,1.07 [0.97-1.19],0.1930809226880802
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40432,386,1.20 [1.09-1.33],0.0001909774963154
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43674,231,1.04 [0.92-1.17],0.5478339332057065
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37500,183,1.03 [0.93-1.14],0.5874904276080595
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39784,9491,0.98 [0.96-1.00],0.1016408981309653
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37393,7100,0.97 [0.95-1.00],0.0220249125085655
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37447,130,0.86 [0.71-1.04],0.1221331880766985
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37948,256,1.02 [0.91-1.13],0.7687199743178055
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37990,298,0.94 [0.84-1.06],0.3165047350669613
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,43311,157,0.96 [0.85-1.09],0.5482795096727004
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",37858,166,0.78 [0.59-1.04],0.086612847807787
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,32218,1925,0.98 [0.93-1.03],0.4190956858280803
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43498,323,0.99 [0.87-1.13],0.922027358675272
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38411,719,0.96 [0.88-1.05],0.398082104708971
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36950,12233,0.99 [0.98-1.01],0.4330991062089926
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40382,200,0.95 [0.83-1.10],0.4993182609356122
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37571,254,1.00 [0.88-1.15],0.9747798678667908
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,38292,975,0.96 [0.91-1.02],0.204295624661187
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,42138,4446,1.02 [0.99-1.05],0.2368690278109098
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37787,470,0.89 [0.78-1.01],0.0702138823842555
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37699,382,0.98 [0.92-1.05],0.6346557931465194
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37549,232,1.04 [0.95-1.15],0.3553071586392714
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42597,115,1.01 [0.82-1.26],0.896855023962498
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,33117,2824,0.98 [0.94-1.02],0.2837801625958612
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,31279,986,1.13 [1.05-1.22],0.0013062130435537
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43596,971,1.16 [1.07-1.25],0.0001418081120093
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30423,130,1.01 [0.88-1.16],0.899393039854558
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30864,571,0.98 [0.92-1.05],0.5641458402249435
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37826,509,1.01 [0.95-1.09],0.6820286367420905
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31368,1075,0.97 [0.91-1.02],0.1984915803135737
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37784,92,1.18 [0.98-1.43],0.0866430924193686
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38746,1054,1.00 [0.94-1.06],0.9813439562067952
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,38198,506,1.01 [0.94-1.09],0.7754535759069641
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31294,1001,0.97 [0.92-1.02],0.2653061830009413
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37442,125,1.08 [0.95-1.22],0.2606154885605991
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37420,103,0.84 [0.66-1.07],0.1518439164941236
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,40304,122,1.00 [0.82-1.23],0.975530778481283
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,43077,2895,0.96 [0.92-1.00],0.0364659356962595
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,42073,1891,0.92 [0.87-0.98],0.008017261945229
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43481,762,1.02 [0.95-1.09],0.6405549880938775
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34466,4173,0.97 [0.94-1.01],0.1386430933971513
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30398,105,0.91 [0.76-1.08],0.2836352724738415
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37471,154,1.05 [0.92-1.20],0.4924867571283776
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30380,87,0.88 [0.62-1.24],0.4515085341583242
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30508,215,0.76 [0.63-0.92],0.0039746390300861
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40595,413,1.01 [0.93-1.09],0.8929883637336583
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,40815,633,1.01 [0.94-1.10],0.7129062094517158
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43678,165,0.90 [0.75-1.09],0.2886794526685556
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40713,3021,1.01 [0.98-1.05],0.495026460076609
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37484,167,0.88 [0.76-1.02],0.0821348930741361
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30533,240,1.01 [0.91-1.13],0.7891986434167035
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38906,1214,1.01 [0.96-1.07],0.6799698207652134
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33925,3632,0.98 [0.95-1.01],0.1284601836285723
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42638,156,0.96 [0.79-1.15],0.640066947675455
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43698,125,1.03 [0.90-1.19],0.6727591503930701
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37455,138,0.95 [0.79-1.14],0.5634300304360783
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39412,2095,1.03 [0.99-1.07],0.1158340923495303
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37465,148,1.02 [0.86-1.20],0.836296250322957
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,33035,2742,0.99 [0.95-1.03],0.6357742644063303
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40379,197,1.02 [0.91-1.15],0.6954079507122932
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37404,87,0.78 [0.60-1.02],0.0701031921992877
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,37957,265,0.94 [0.81-1.09],0.3883498265438121
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,38233,916,1.06 [0.99-1.13],0.0796917930276026
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,43087,605,0.99 [0.90-1.08],0.7809689527240814
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38654,962,1.01 [0.95-1.07],0.8107993309947444
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43501,742,1.03 [0.97-1.11],0.3255529048545692
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43691,88,1.12 [0.95-1.33],0.1732226606854243
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37640,323,0.91 [0.81-1.02],0.0933925596661453
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34610,1265,0.96 [0.90-1.01],0.1337994908523733
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,38289,972,1.04 [0.98-1.10],0.2070127868628932
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37708,391,0.89 [0.76-1.03],0.1188116874915327
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30390,97,0.97 [0.77-1.21],0.7537299761261518
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34482,4189,1.00 [0.96-1.03],0.8519259687001997
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31386,1093,0.97 [0.91-1.04],0.4685577001267587
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,42866,384,1.00 [0.86-1.16],0.9963569456099852
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43619,106,0.91 [0.72-1.15],0.4331983143385053
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",40110,83,1.20 [1.00-1.45],0.0542706660711691
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30421,128,1.02 [0.89-1.18],0.7460378697429288
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,37862,170,1.02 [0.89-1.18],0.7373945386352998
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,31065,772,1.01 [0.95-1.08],0.714084296251428
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37840,523,0.94 [0.85-1.04],0.2261555403470645
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,38115,423,1.06 [0.98-1.15],0.1393480334163575
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,37998,306,0.98 [0.85-1.12],0.7266722955604512
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,34207,103,0.95 [0.77-1.16],0.6143661832527147
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43699,96,1.10 [0.93-1.31],0.2573525663462678
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,38308,991,1.00 [0.94-1.05],0.9068261331358624
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],42649,167,0.92 [0.80-1.07],0.297065767805325
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41674,4357,1.00 [0.98-1.03],0.8474819201288449
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37542,225,0.99 [0.87-1.13],0.9078158054109572
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38577,885,1.00 [0.92-1.08],0.9381228820219611
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,41299,389,0.99 [0.89-1.10],0.8279189919087606
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,38021,329,0.90 [0.78-1.04],0.1384755181682486
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,40274,2582,1.02 [0.98-1.06],0.3123062441129946
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39385,1693,1.01 [0.96-1.07],0.6073931749569523
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37404,87,1.11 [0.95-1.30],0.1716438846382243
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42731,249,1.04 [0.96-1.13],0.3671826953843057
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37598,281,0.97 [0.87-1.08],0.6127169759932793
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37450,133,0.98 [0.83-1.16],0.8143411320233671
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30389,96,1.01 [0.82-1.24],0.9069923448970578
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,42145,2529,1.14 [1.09-1.19],2.2947050310293235e-09
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17718,85,1.03 [0.93-1.14],0.559340642770018
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23071,100,1.14 [1.05-1.25],0.0024461689612032
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,43199,532,1.00 [0.92-1.10],0.9311280634200368
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,42810,143,1.00 [0.78-1.27],0.971519557600131
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,41894,2278,1.24 [1.19-1.29],2.3652466143776846e-26
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,43391,104,1.47 [1.27-1.70],1.9769350863962725e-07
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,43348,487,1.13 [1.03-1.24],0.0121343699950315
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Cystitis,38633,392,1.06 [0.96-1.17],0.2845821941435204
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Dialysis,39728,112,1.42 [1.26-1.59],4.107321176763785e-09
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19012,2770,1.18 [1.11-1.26],9.244349424085284e-07
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23253,282,1.08 [1.01-1.15],0.0158055931615234
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17781,148,1.02 [0.95-1.10],0.5631385474565138
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17968,335,1.07 [1.03-1.11],0.0006937306927375
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18486,853,1.01 [0.95-1.06],0.8346353040988471
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36526,8902,1.11 [1.09-1.13],3.872501177377835e-28
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43409,122,1.14 [0.99-1.32],0.0676774312946879
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16411,169,1.17 [0.89-1.55],0.2558131625404298
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39563,467,1.04 [0.94-1.14],0.4448780610701733
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18415,2173,1.23 [1.14-1.33],3.775632827332846e-08
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23187,344,1.03 [0.96-1.09],0.4267142380475114
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16435,193,1.40 [1.11-1.77],0.0046287620673882
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23269,107,1.04 [0.97-1.12],0.2272695622777236
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17895,262,1.08 [1.04-1.13],0.000230734685961
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38362,121,1.00 [0.82-1.20],0.9629670819057996
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19722,2089,1.03 [1.00-1.05],0.0481935635197262
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16342,100,1.33 [0.95-1.87],0.0947533525615763
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17754,121,1.02 [0.93-1.11],0.7147241676972858
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43713,109,1.18 [1.01-1.39],0.0406060265556568
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43711,115,1.05 [0.87-1.26],0.6059508083882361
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,41950,3709,1.08 [1.04-1.11],8.30798461364869e-06
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39447,1206,0.97 [0.89-1.05],0.4209827509176563
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23070,99,0.92 [0.78-1.07],0.2806089738214699
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43620,759,1.15 [1.08-1.23],4.448822522256475e-05
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16499,257,1.17 [0.93-1.47],0.1778282570938412
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16477,235,0.87 [0.68-1.13],0.3021369250721054
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16430,188,1.29 [1.00-1.65],0.0457852120075573
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43664,117,0.98 [0.81-1.18],0.8132919005455886
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,41076,2835,1.10 [1.06-1.14],5.963195535973935e-08
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23022,179,1.07 [0.99-1.16],0.0819967690756451
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17765,132,0.98 [0.87-1.11],0.7814254163369735
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17967,334,1.03 [0.97-1.10],0.2873850693545614
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17736,103,0.85 [0.71-1.03],0.0918250081030697
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17815,182,0.99 [0.89-1.10],0.8397898327349144
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39643,547,1.07 [0.99-1.17],0.0867979101979102
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,43113,252,1.16 [1.04-1.30],0.0076843466253195
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17883,250,0.95 [0.88-1.04],0.2636230010801954
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17723,90,1.03 [0.94-1.14],0.5127673036346345
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18176,543,1.01 [0.97-1.06],0.5864954162615046
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17770,137,1.08 [0.96-1.22],0.1965766801526669
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18137,504,1.00 [0.94-1.05],0.8676542393855211
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,43372,85,1.03 [0.83-1.28],0.7687441584430755
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16463,221,1.17 [0.92-1.49],0.204182091519463
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,43355,4259,1.14 [1.10-1.17],1.3305249110956953e-15
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",39295,199,1.00 [0.90-1.12],0.9466217703427912
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39815,199,1.27 [1.12-1.44],0.0001662002645805
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42760,93,0.96 [0.78-1.18],0.6861903233577215
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38610,369,1.00 [0.88-1.13],0.9644156322369892
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,43333,666,1.02 [0.94-1.10],0.6329927766938335
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17751,118,0.98 [0.89-1.09],0.7208938979261081
